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Figure 1 | Initial bone scintigraphy reveals multiple osseous and
nonosseous uptake at thoracolumbar spine (arrows), rib cage
R Anterior Posterior R
Figure 2 | Bone scintigraphy after treatment reveals completely
resolved nonosseous metastatic calciﬁcation in stomach and
lung, and also less intense osseous uptakes at the thoracolumbar
spine (arrows) and rib cage (arrowheads).A 63-year-old man was admitted to the nephrology wardwith low back pain, anorexia, upper abdominal pain,cough, and exertional dyspnea, which he had for
several weeks. He was pale and anicteric, and decreased skin
turgor and bruises were noted. One year before his admission,
he was diagnosed with extramammary Paget’s disease over the
left scrotum and inguinal area, and had received surgical exci-
sion. Initial laboratory testing revealed pancytopenia with
immature cells and erythroblasts. Serum chemistry showed
blood urea nitrogen 131 mg/dl, creatinine 5.53 mg/dl, cal-
cium 14.7 mg/dl, phosphate 7.0 mg/dl, albumin 4.31 g/dl,
intact parathyroid hormone 6.1 pg/ml, 25-hydroxyvitamin
D 20 ng/ml, and 1,25-dihydroxyvitamin D 12.9 pg/ml. Mono-
clonal gammopathy was not seen on serum and urine electro-
phoresis. Serum free light chain assay results were normal.
Computed tomography showed tumor recurrence in the peri-
neum with multiple lymph node (inguinal, pelvic, and iliac)
enlargements and osteolytic lesions of bone.
Tc-99m methylene diphosphonate bone scintigraphy
(Figure 1) revealed multiple focal areas of increased uptake
(ﬁlled arrowheads), stomach (open arrowheads), and diffuse
pulmonary metastatic calciﬁcation.1134involving the thoracolumbar spine, rib cage, and left acetab-
ulum. There was also increased uptake over both lung ﬁelds
and gastric area, suggestive of metastatic calciﬁcation. Bone
marrow biopsy from the patient’s right iliac crest revealed
metastatic poorly differentiated carcinoma, which was positive
for human epidermal growth factor receptor 2. After treat-
ment of hypercalcemia with saline solution hydration and loop
diuretics, the patient received human epidermal growth factor
receptor 2–targeted therapy with weekly 120 mg trastuzumab
i.v. injection. Twelve weeks later, the patient’s serum creatinine
level decreased to 1.08 mg/dl and calcium was 9.9 mg/dl.
Repeated bone scintigraphy (Figure 2) revealed completely
resolved metastatic calciﬁcation in the stomach and lungs,
and also less evidence of other osseous uptakes at the thor-
acolumbar spine and rib cage.
Nonosseous accumulation of the bone marker Tc-99m
methylene diphosphonate may occur in hypercalcemic syn-
dromes. Lung involvement may be symptomatic and some-
times severe. Abnormalities typically improve with resolution
of hypercalcemia.Kidney International (2016) 90, 1134
